Clinical Trial Update: An Extended Access Program (EAP) for Perampanel

View source ↗

Summary

The extended access program for perampanel has ended and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Tonic-clonic Seizures
• Lennox-gastaut Syndrome
• Partial-onset Seizures

Drugs mentioned

• Perampanel (Fycompa) (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Primary Generalized Tonic-Clonic or Partial Onset Seizures, Lennox Gastaut Syndrome | Status: NO_LONGER_AVAILABLE